Bank Julius Baer & Co. Ltd, Zurich Arcturus Therapeutics Holdings Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

  • $26 Billion
  • Q1 2024

A detailed history of Bank Julius Baer & Co. Ltd, Zurich transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Bank Julius Baer & Co. Ltd, Zurich holds 43,762 shares of ARCT stock, worth $940,007. This represents 0.01% of its overall portfolio holdings.

Number of Shares
43,762
Previous 47,232 7.35%
Holding current value
$940,007
Previous $1.49 Million 0.81%
% of portfolio
0.01%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$31.23 - $42.99 $108,368 - $149,175
-3,470 Reduced 7.35%
43,762 $1.48 Million
Q4 2023

May 16, 2024
BUY
$17.71 - $32.97 $61,453 - $114,405
3,470 Added 7.93%
47,232 $1.49 Million
Q4 2023

Feb 02, 2024
SELL
$17.71 - $32.97 $195,305 - $363,593
-11,028 Reduced 18.93%
47,232 $1.49 Million
Q3 2023

Nov 13, 2023
SELL
$25.44 - $37.35 $39,915 - $58,602
-1,569 Reduced 2.62%
58,260 $1.49 Million
Q2 2023

Jul 24, 2023
BUY
$23.94 - $32.36 $1.43 Million - $1.94 Million
59,829 New
59,829 $1.72 Million
Q1 2023

May 11, 2023
BUY
$14.72 - $23.97 $55,141 - $89,791
3,746 Added 5.65%
70,070 $1.68 Million
Q4 2022

Jan 24, 2023
BUY
$14.14 - $23.06 $94,836 - $154,663
6,707 Added 11.25%
66,324 $1.13 Million
Q3 2022

Nov 04, 2022
SELL
$13.05 - $22.13 $851,134 - $1.44 Million
-65,221 Reduced 52.24%
59,617 $884,000
Q2 2022

Jul 22, 2022
SELL
$12.26 - $31.17 $1.13 Million - $2.88 Million
-92,425 Reduced 42.54%
124,838 $1.97 Million
Q1 2022

May 09, 2022
SELL
$17.64 - $39.57 $862,719 - $1.94 Million
-48,907 Reduced 18.37%
217,263 $5.86 Million
Q4 2021

Feb 15, 2022
SELL
$34.2 - $47.56 $14.2 Million - $19.7 Million
-414,079 Reduced 60.87%
266,170 $9.85 Million
Q3 2021

Nov 12, 2021
SELL
$27.88 - $58.25 $628,108 - $1.31 Million
-22,529 Reduced 3.21%
680,249 $32.5 Million
Q2 2021

Jul 23, 2021
BUY
$25.79 - $42.11 $7.41 Million - $12.1 Million
287,237 Added 69.12%
702,778 $23.8 Million
Q1 2021

May 10, 2021
BUY
$38.75 - $86.92 $3.08 Million - $6.91 Million
79,464 Added 23.64%
415,541 $17.2 Million
Q4 2020

Feb 24, 2021
SELL
$34.61 - $123.66 $6.83 Million - $24.4 Million
-197,254 Reduced 36.99%
336,077 $14.6 Million
Q4 2020

Feb 12, 2021
BUY
$34.61 - $123.66 $13.8 Million - $49.2 Million
398,063 Added 294.28%
533,331 $14.6 Million
Q3 2020

Nov 10, 2020
BUY
$37.49 - $63.19 $5.07 Million - $8.55 Million
135,268 New
135,268 $5.9 Million

Others Institutions Holding ARCT

# of Institutions
196
Shares Held
26.7M
Call Options Held
294K
Put Options Held
318K
View Full List

About Arcturus Therapeutics Holdings Inc.

ARCT Quotes by TradingView
  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $571M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Bank Julius Baer & Co. Ltd, Zurich Portfolio

Follow Bank Julius Baer & Co. Ltd, Zurich and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

News

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email